%0 Journal Article %T Revolutionary changes in salvage treatment for Hodgkin lymphoma: toward a chemotherapy-free future %A Chen, Jiawen %A Yang, Wei %A Gong, Zimu %J Annals of Translational Medicine %D 2018 %B 2018 %9 %! Revolutionary changes in salvage treatment for Hodgkin lymphoma: toward a chemotherapy-free future %K %X Recently, O’Connor et al . reported the high activity of the combination of brentuximab vedotin (BV) and bendamustine in relapsed/refractory Hodgkin’s lymphoma (HL) patients (1). The study is notable for the heavily treated population and relatively large sample size. %U https://atm.amegroups.org/article/view/19768 %V 6 %N 11 %P 237 %@ 2305-5847